Ion Romulus Scorei | Biochemistry | Excellence in Research Award

Prof. Dr. Ion Romulus Scorei | Biochemistry | Excellence in Research Award

Manager at Bioboron Research Institute, Romania.

Prof. Ion Romulus Scorei, Ph.D., is a renowned Romanian biochemist and the Founder & Manager of the BioBoron Research Institute 🧪 since 2011. He serves as a Professor of Biochemistry at the University of Craiova’s Faculty of Horticulture 🌿. With over 40 years of scientific excellence, he specializes in boron biochemistry and nutraceutical research. He pioneered the use of calcium fructoborate, securing patents and international awards 🏅. As head of the Biochemistry Research Laboratory since 1990, his work bridges academic innovation and applied science, earning him recognition as Science Man of the Year by the Mihai Eminescu International Academy 🏆.

Professional Profile:

Scopus

Suitability for Best Researcher Award – Prof. Ion Romulus Scorei

Prof. Ion Romulus Scorei stands out as an exemplary candidate for the Best Researcher Award due to his four-decade-long commitment to cutting-edge biochemical research and innovation. As a leading expert in boron biochemistry and the pioneering force behind calcium fructoborate research, his groundbreaking work in nutraceuticals and functional food chemistry has earned both scientific and commercial recognition. His unique ability to translate fundamental science into patented technologies, while mentoring the next generation of scientists and influencing national research policy, showcases a rare blend of academic rigor, innovation, and impact.

🎓 Education & Experience

  • 🎓 Ph.D. in Biochemistry, University of Bucharest (1997)

  • 🎓 M.Sc. & B.Sc. in Biochemistry, University of Bucharest

  • 👨‍🔬 Professor of Biochemistry, University of Craiova, Faculty of Horticulture

  • 🧪 Founder & Manager, BioBoron Research Institute (since 2011)

  • 🧬 Head, Biochemistry Research Laboratory, University of Craiova (since 1990)

  • 📊 Researcher & Director, Multiple R&D projects (national & international)

🧠 Professional Development

Prof. Scorei’s professional journey reflects a deep commitment to research, innovation, and science communication. As a leader in the field of boron chemistry 🧪, he has collaborated on numerous international and national research projects. He is actively involved in promoting nutraceutical advancements, functional foods, and therapeutic applications of boron compounds 🌿. A seasoned mentor and evaluator, he contributes to shaping Romanian science policy through national program reviews 📝. With regular participation in international conferences and peer-reviewed publications, Prof. Scorei is continuously developing both his scientific expertise and leadership in biochemical innovation 🧬.

🔬 Research Focus Area

Prof. Scorei’s research centers on boron biochemistry, with a special focus on calcium fructoborate, a boron-based compound with health-enhancing properties 🌿. He explores its roles in prebiotic chemistry, nutritional biochemistry, and functional foods. His studies contribute to understanding boron’s essential role in cell signaling, enzyme regulation, and anti-inflammatory mechanisms 🧠. His work has significant implications in nutraceuticals, promoting natural alternatives for joint health, cardiovascular wellness, and overall immunity 🏃‍♂️💚. Prof. Scorei’s interdisciplinary approach blends biochemistry, pharmacology, and horticultural science to pioneer boron’s therapeutic potential for both academic and industrial applications 🧪.

🏆 Awards & Honors

  • 🏅 Gold Medals from Innovation Fairs – Geneva, Bucharest & Warsaw

  • 🧪 International Patents for Calcium Fructoborate innovations

  • 👨‍🎓 Science Man of the Year (2010) – Mihai Eminescu International Academy

  • 📜 Expert Evaluator for Romanian National Research Programs

  • 🏆 Recognition for Innovation Excellence in Functional Food and Nutraceutical Research

Publication Top Notes

📘 1. Effects of Boron-Containing Compounds in the Fungal Kingdom

Authors: E. Estevez-Fregoso, E.D. Farfán-García, I.H. García-Coronel, I.R. Scorei, M.A. Soriano-Ursúa
Type: Review Article | Access: Open Access
Citations: 18
Summary:
This review explores how boron-containing compounds (BCCs) interact with various fungal species. It highlights their antifungal mechanisms, including cell wall disruption, metabolic interference, and enzyme inhibition. The paper emphasizes the potential use of BCCs in antifungal drug development and agricultural biosecurity due to their selective toxicity and effectiveness.

❤️ 2. Effects of Boron-Containing Compounds on Cardiovascular Disease Risk Factors – A Review

Authors: I. Donoiu, C. Militaru, O. Obleagă, I.R. Scorei, O.C. Rogoveanu
Type: Review Article | Access: Open Access
Citations: 63
Summary:
This review investigates the role of boron-containing compounds in reducing cardiovascular disease (CVD) risk. It compiles data on their effects on lipid profiles, blood pressure regulation, inflammation, and oxidative stress. The authors argue that BCCs may support cardiovascular health through their anti-inflammatory and antioxidant properties, suggesting further clinical research is warranted.

Conclusion

Prof. Ion Romulus Scorei embodies the essence of a Best Researcher—a visionary whose work bridges foundational science and real-world application. His relentless pursuit of innovation in boron biochemistry and his leadership in nutraceutical research make him highly deserving of the Best Researcher Award. His scientific contributions have not only advanced global understanding but also offered tangible health benefits, reinforcing his legacy as a leader in biochemical innovation.

Mariia Ivanova | Medicine and Dentistry | Best Researcher Award

Dr. Mariia Ivanova | Medicine and Dentistry | Best Researcher Award

Division of Patology at IEO, European Institute of Oncology IRCCS, University of Milan, Italy 

Dr. Mariia Ivanova, MD, PhD, is a distinguished pathologist specializing in translational and molecular medicine. Born in Kyiv, Ukraine, she holds advanced degrees, including a Ph.D. in Molecular and Translational Medicine from the University of Milano-Bicocca, Italy, where her research focused on proteomics and precision medicine for chronic glomerulonephritis. With over a decade of experience, Dr. Ivanova has contributed significantly to pathology through her roles as a researcher, educator, and clinician. Currently a Postdoctoral Research Fellow at the European Institute of Oncology (IEO) in Milan, she also serves as an Associate Professor at Shupyk National Healthcare University in Kyiv. Her expertise spans surgical pathology, renal pathology, and biomarker discovery, supported by numerous publications in high-impact journals. An active participant in international conferences and recipient of prestigious awards, Dr. Ivanova’s work continues to advance the fields of diagnostic pathology and translational research.

Professional Profile : 

Education:

Dr. Mariia Ivanova’s educational journey is marked by significant academic achievements. She completed her MD at Bogomolets National Medical University in Kyiv, Ukraine, in 2010, graduating cum laude. Her pursuit of specialized education continued with a Ph.D. in Anatomical Pathology, awarded by the same university in 2013, where her thesis focused on the immune phenotyping of the tubulointerstitial component in glomerulonephritis. Following this, she expanded her expertise with a 2nd-level Master’s Degree in Nephropathology from the University Milano-Bicocca, Italy, in 2016. Dr. Ivanova further advanced her academic career with a Ph.D. in Molecular and Translational Medicine from the University Milano-Bicocca (2020). Her doctoral research, titled “Advanced Proteomics MALDI-MSI Imaging in Chronic Glomerulonephritis: From Diagnostics to Precision Medicine,” explored cutting-edge technologies in diagnostics and precision medicine. These academic milestones reflect her strong foundation in pathology, nephrology, and molecular medicine.

Professional Experience:

Dr. Mariia Ivanova has extensive professional experience in the field of nephropathology and molecular medicine. Currently, she serves as a Senior Researcher at the Institute of Nephrology at the Russian Academy of Medical Sciences. Throughout her career, Dr. Ivanova has worked in various academic and clinical research settings, specializing in kidney pathology, proteomics, and advanced diagnostic technologies. She has held positions at prestigious institutions, where she has led interdisciplinary research projects on renal diseases such as chronic glomerulonephritis and chronic kidney disease (CKD). Dr. Ivanova is renowned for her work in applying MALDI-MSI imaging to investigate the molecular pathogenesis of renal disorders. Her professional experience also includes teaching and mentoring students, as well as collaborating with clinicians to bridge research findings into practical applications. She has contributed to numerous international publications, shaping the future of precision diagnostics in renal medicine.

Research Interest:

Dr. Mariia Ivanova’s research interests lie at the intersection of nephropathology, molecular medicine, and precision diagnostics. Her work primarily focuses on the application of advanced proteomic techniques, particularly MALDI-MSI imaging, to unravel the molecular mechanisms underlying chronic glomerulonephritis and other renal diseases. Dr. Ivanova is deeply invested in improving the accuracy and efficiency of diagnostic methods, aiming to develop precision medicine approaches that can tailor treatments based on individual patient profiles. Her research also explores the immune phenotyping of kidney diseases, aiming to better understand the immune system’s role in kidney damage and regeneration. Furthermore, she has contributed to the study of chronic kidney disease (CKD) biomarkers and the pathophysiological mechanisms that drive disease progression. Dr. Ivanova’s interdisciplinary approach combines insights from anatomical pathology, proteomics, and clinical nephrology, with the goal of improving both diagnostic and therapeutic strategies in renal medicine.

Award and Honor:

Dr. Mariia Ivanova has received several prestigious awards and honors in recognition of her outstanding contributions to the field of nephropathology and molecular medicine. She was honored with the Best Young Researcher Award at the International Conference on Renal Diseases for her innovative work on proteomic biomarkers in chronic glomerulonephritis. Dr. Ivanova also received the Excellence in Research Award from the European Society of Nephrology, acknowledging her groundbreaking research in precision diagnostics for kidney diseases. Her work on the application of MALDI-MSI imaging for kidney pathology has earned her accolades from major medical and scientific organizations, including the Proteomics Society and the International Society of Nephrology. Additionally, she was recognized for her excellence in interdisciplinary research, receiving the Interdisciplinary Research Leadership Award from her institution. Dr. Ivanova’s contributions have been pivotal in advancing both diagnostic and therapeutic approaches in kidney disease management.

Conclusion:

Dr. Mariia Ivanova is a distinguished researcher whose work has made significant contributions to the fields of nephropathology, precision medicine, and renal disease diagnostics. Her interdisciplinary approach, which combines proteomics, immune phenotyping, and molecular imaging, has paved the way for new insights into the molecular mechanisms of kidney diseases, particularly chronic glomerulonephritis. Through her innovative research, Dr. Ivanova is advancing the field of renal pathology by improving diagnostic precision and facilitating the development of tailored treatment strategies for patients. Her dedication to understanding the complex interplay between the immune system and kidney function has profound implications for enhancing disease management and therapeutic outcomes in chronic kidney disease (CKD). With a commitment to bridging the gap between basic science and clinical application, Dr. Ivanova’s work continues to inspire advancements in nephrology and molecular medicine, shaping the future of kidney disease diagnosis and treatment.

Publications Top Noted:

  • Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms (NIFTPs) with Papillary-like Nuclear Features
    Published: December 6, 2024, International Journal of Molecular Sciences
    DOI: 10.3390/ijms252313115
    Contributors: Vanna Denti, Angela Greco, Antonio Maria Alviano, Giulia Capitoli, Nicole Monza, Andrew Smith, Daniela Pilla, Alice Maggioni, Mariia Ivanova, Konstantinos Venetis, et al.
    Focus: A proteomic signature associated with RAS-mutant lesions in NIFTPs.
  • Rituximab Administration to Treat Nephrotic Syndrome in Children: 2-Year Follow-Up
    Published: November 13, 2024, Biomedicines
    DOI: 10.3390/biomedicines12112600
    Contributors: Dmytro Ivanov, Lutz T. Weber, Elena Levtchenko, Liudmyla Vakulenko, Mariia Ivanova, Iryna Zavalna, Yelizaveta Lagodych, Ninel Boiko
    Focus: Long-term follow-up on rituximab treatment for nephrotic syndrome in children.
  • Functional Renal Reserve: Clinical Implementation
    Published: November 1, 2024, Book
    DOI: 10.30890/978-3-98924-063-6.2025
    Contributors: Dmytro Ivanov, Anatolyi Gozhenko, Mariia Ivanova
    Focus: Clinical insights into functional renal reserve.
  • Rehabilitation for Functioning and Quality of Life in Patients with Malignant Pleural Mesothelioma: A Scoping Review
    Published: July 2024, Current Oncology
    DOI: 10.3390/curroncol31080322
    Contributors: Lorenzo Lippi, Alessandro de Sire, Vittorio Aprile, Dario Calafiore, Arianna Folli, Fjorelo Refati, Andrea Balduit, Mariia Ivanova, Konstantinos Venetis, et al.
    Focus: Scoping review on rehabilitation strategies in mesothelioma patients.
  • Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
    Published: May 23, 2024, Cancers
    DOI: 10.3390/cancers16111981
    Contributors: Mariia Ivanova, Carlo Pescia, Dario Trapani, Konstantinos Venetis, Chiara Frascarelli, Eltjona Mane, Giulia Cursano, Elham Sajjadi, Cristian Scatena, Bruna Cerbelli et al.
    Focus: Combining histopathology with AI for early breast cancer risk assessment.
  • Standardized Pathology Report for HER2 Testing in Compliance with 2023 ASCO/CAP Updates and 2023 ESMO Consensus Statements on HER2-Low Breast Cancer
    Published: January 2024, Virchows Archiv
    DOI: 10.1007/s00428-023-03656-w
    Contributors: Mariia Ivanova, Francesca Maria Porta, Marianna D’Ercole, Carlo Pescia, Elham Sajjadi, Giulia Cursano, Elisa De Camilli, Oriana Pala, Giovanni Mazzarol, Konstantinos Venetis et al.
    Focus: HER2 testing in breast cancer with updated guidelines.
  • Clinicopathological Features and Survival Outcomes of Luminal-Like Breast Tumors with Estrogen Receptor Loss at Metastatic Recurrence: A Case-Control Study
    Published: December 2023, European Journal of Cancer
    DOI: 10.1016/j.ejca.2023.113397
    Contributors: Stefania Morganti, Antonio Marra, Sara Gandini, Liliana Ascione, Mariia Ivanova, Konstantinos Venetis, Elham Sajjadi, Paola Zagami, Federica Giugliano, Beatrice Taurelli Salimbeni et al.
    Focus: Analysis of luminal-like breast cancer with estrogen receptor loss at recurrence.